You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昊海生科(688366.SH):醫學部醫學總監、核心技術人員艾建華因個人原因辭職
格隆匯 01-10 17:04

格隆匯1月10日丨昊海生科(688366.SH)公佈,公司醫學部醫學總監、核心技術人員艾建華因個人原因辭去相關職務,並於近日辦理完畢離職手續。離職後,艾建華將不在公司擔任任何職務。

經公司研究決定,聘任苗紅為新任醫學部醫學總監。艾建華的離職不會對公司技術研發及生產經營帶來實質性影響,不會影響公司持有的核心技術,不存在涉及職務發明的糾紛或潛在糾紛。

艾建華任職期間參與的在研項目共計兩項,分別為“皮膚屏障修復劑的研製”以及“智能型藥物緩釋材料的開發”。其中,艾建華承擔上述兩個項目的項目立項、醫學和市場評估工作。以上兩項在研產品目前尚處於研發初期,公司參與上述兩項產品研發項目的技術人員還包括核心技術人員侯永泰、魏長征、蔣麗霞、杜鵬以及其它數名研發人員。艾建華的離職不會影響上述項目的推進與實施。

除上述情況外,艾建華未參與其它在研項目,亦未涉及公司其它核心技術研發,不會對公司現有研發項目進展產生影響。

截至公告日,艾建華並未參與公司專利研究及申報。

公司與艾建華簽署了《保密協議》及《競業限制協議》,根據與公司簽署的《保密協議》,艾建華無論何種原因離職,均應對其在公司任職期間接觸、知悉的屬於公司的技術祕密或商業祕密負有保密義務。不得泄露、告知、公佈、發佈、出版、傳授、轉讓或者以其它任何方式使任何第三方知悉屬於公司的技術祕密或商業祕密。根據與公司簽署的《競業限制協議》,公司會支付約定的競業限制經濟補償,要求艾建華離職後兩年內不得到競爭對手處工作。

截至公告日,公司未發現艾建華先生離職後前往競爭對手處工作的情形,未發現艾建華存在違反競業限制協議的情形。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account